IL-33/ST2 as a potential target for tumor immunotherapy

Jiang, WY; Lian, JY; Yue, Y; Zhang, Y

Zhang, Y (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Biotherapy Ctr, Zhengzhou, Henan, Peoples R China.; Zhang, Y (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Canc Ctr, Zhengzhou, Henan, Peoples R China.; Zhang, Y (corresponding author), State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou, Henan, Peoples R China.; Zhang, Y (corresponding author), Henan Key Lab Tumor Immunol & Biotherapy, Zhengzhou, Henan, Peoples R China.

EUROPEAN JOURNAL OF IMMUNOLOGY, 2021; 51 (8): 1943

Abstract

IL-33, a member of the IL-1 family, was initially reported to be expressed constitutively in the nucleus of tissue-lining and structural cells. Howeve......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索